<DOC>
	<DOCNO>NCT00073515</DOCNO>
	<brief_summary>This trial patient central venous catheter ( vascular access device ) function properly ( unable withdraw blood ) . The trial compare new blood clot dissolve agent ( alfimeprase ) currently use treatment .</brief_summary>
	<brief_title>Trial Novel Fibrinolytic ( Alfimeprase ) Clear Thrombosed Vascular Access Devices</brief_title>
	<detailed_description />
	<criteria>Subjects must : dysfunctional Central Venous Access Device ( CVAD ) define unable withdraw 3 mL blood device place &gt; 48 hour clinically stable 18 old give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>central venous access device</keyword>
	<keyword>thrombosis</keyword>
	<keyword>central venous catheter</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>fibrinolysis</keyword>
</DOC>